Publications
416 found
Show per page
Asla, Queralt, Garrido, Maite, Urgell, Eulàlia, Terzan, Sílvia, Santos, Alicia, Fernández, Mercè, Varghese, Nimmy, Atila, Cihan, Calabrese, Anna, Biagetti, Betina, Plessow, Franziska, Gich, Ignasi, Scientific Reports, 15(1), 2360. https://doi.org/10.1038/s41598-025-86566-y
, Eckert, Anne, Webb, Susan M., Lawson, Elizabeth A., & Aulinas, Anna. (2025). Oxytocin levels in response to CRH administration in hypopituitarism and hypothalamic damage: a randomized, crossover, placebo-controlled trial.
Asla, Queralt, Garrido, Maite, Urgell, Eulàlia, Terzan, Sílvia, Santos, Alicia, Fernández, Mercè, Varghese, Nimmy, Atila, Cihan, Calabrese, Anna, Biagetti, Betina, Plessow, Franziska, Gich, Ignasi, Scientific Reports, 15(1), 2360. https://doi.org/10.1038/s41598-025-86566-y
, Eckert, Anne, Webb, Susan M., Lawson, Elizabeth A., & Aulinas, Anna. (2025). Oxytocin levels in response to CRH administration in hypopituitarism and hypothalamic damage: a randomized, crossover, placebo-controlled trial.
Atila, Cihan, Lustenberger, Sven, Chifu, Irina, Ferrante, Emanuele, Erlic, Zoran, Drummond, Juliana B., Indirli, Rita, Drexhage, Roosmarijn, Powlson, Andrew S., Gurnell, Mark, Santana Soares, Beatriz, Hofland, Johannes, Beuschlein, Felix, Fassnacht, Martin, Winzeler, Bettina, Refardt, Julie, & Pituitary, 28. https://doi.org/10.1007/s11102-024-01489-7
. (2025). Relationship between plasma urea and copeptin in response to arginine stimulation in healthy adults, patients with vasopressin deficiency and primary polydipsia.
Atila, Cihan, Lustenberger, Sven, Chifu, Irina, Ferrante, Emanuele, Erlic, Zoran, Drummond, Juliana B., Indirli, Rita, Drexhage, Roosmarijn, Powlson, Andrew S., Gurnell, Mark, Santana Soares, Beatriz, Hofland, Johannes, Beuschlein, Felix, Fassnacht, Martin, Winzeler, Bettina, Refardt, Julie, & Pituitary, 28. https://doi.org/10.1007/s11102-024-01489-7
. (2025). Relationship between plasma urea and copeptin in response to arginine stimulation in healthy adults, patients with vasopressin deficiency and primary polydipsia.
Newell-Price, John, Drummond, Juliana Beaudette, Gurnell, Mark, Levy, Miles, McCormack, Ann, Cooper, Deborah, Wass, John, Journal of Clinical Endocrinology and Metabolism, 110(2), e506–e514. https://doi.org/10.1210/clinem/dgae565
, & Verbalis, Joseph G. (2025). Approach to the Patient With Suspected Hypotonic Polyuria.
Newell-Price, John, Drummond, Juliana Beaudette, Gurnell, Mark, Levy, Miles, McCormack, Ann, Cooper, Deborah, Wass, John, Journal of Clinical Endocrinology and Metabolism, 110(2), e506–e514. https://doi.org/10.1210/clinem/dgae565
, & Verbalis, Joseph G. (2025). Approach to the Patient With Suspected Hypotonic Polyuria.
Pelouto, A., Monnerat, S., Refardt, J., Zandbergen, A. A. M., Christ-Crain, M., & Hoorn, E. J. (2025). Clinical factors associated with hyponatremia correction during treatment with oral urea [Journal-article]. Nephrology Dialysis Transplantation, 40(2), 283–293. https://doi.org/10.1093/ndt/gfae164
Pelouto, A., Monnerat, S., Refardt, J., Zandbergen, A. A. M., Christ-Crain, M., & Hoorn, E. J. (2025). Clinical factors associated with hyponatremia correction during treatment with oral urea [Journal-article]. Nephrology Dialysis Transplantation, 40(2), 283–293. https://doi.org/10.1093/ndt/gfae164
Perrild, Hans, Luger, Anton, Bertherat, Jerome, Quinton, Richard, European Journal of Endocrinology, 192(1), C1–C4. https://doi.org/10.1093/ejendo/lvae169
, Brouwer, Teri, & Durkan, Maeve. (2025). Postgraduate training and continuous medical education in endocrinology in Europe.
Perrild, Hans, Luger, Anton, Bertherat, Jerome, Quinton, Richard, European Journal of Endocrinology, 192(1), C1–C4. https://doi.org/10.1093/ejendo/lvae169
, Brouwer, Teri, & Durkan, Maeve. (2025). Postgraduate training and continuous medical education in endocrinology in Europe.
Smit, J. M., Van Der Zee, P. A., Stoof, S. C. M., Van Genderen, M. E., Snijders, D., Boersma, W. G., Confalonieri, P., Salton, F., Confalonieri, M., Shih, M.-C., Meduri, G. U., Dequin, P.-F., Le Gouge, A., Lloyd, M., Karunajeewa, H., Bartminski, G., Fernández-Serrano, S., Suárez-Cuartín, G., van Klaveren, D., et al. (2025). Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials. The Lancet Respiratory Medicine. https://doi.org/10.1016/S2213-2600(24)00405-3
Smit, J. M., Van Der Zee, P. A., Stoof, S. C. M., Van Genderen, M. E., Snijders, D., Boersma, W. G., Confalonieri, P., Salton, F., Confalonieri, M., Shih, M.-C., Meduri, G. U., Dequin, P.-F., Le Gouge, A., Lloyd, M., Karunajeewa, H., Bartminski, G., Fernández-Serrano, S., Suárez-Cuartín, G., van Klaveren, D., et al. (2025). Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials. The Lancet Respiratory Medicine. https://doi.org/10.1016/S2213-2600(24)00405-3
Gregoriano, Claudia, Wirz, Yannick, Heinsalo, Ashley, Annane, Djilali, Reinhart, Konrad, Bouadma, Lila, BMC Cancer, 24(1). https://doi.org/10.1186/s12885-024-13160-2
, Kristoffersen, Kristina B., Damas, Pierre, Nobre, Vandack, Oliveira, Carolina F., Shehabi, Yahya, Stolz, Daiana, Verduri, Alessia, Mueller, Beat, & Schuetz, Philipp. (2024). Procalcitonin-guided antibiotic treatment in patients with cancer: a patient-level meta-analysis from randomized controlled trials.
Gregoriano, Claudia, Wirz, Yannick, Heinsalo, Ashley, Annane, Djilali, Reinhart, Konrad, Bouadma, Lila, BMC Cancer, 24(1). https://doi.org/10.1186/s12885-024-13160-2
, Kristoffersen, Kristina B., Damas, Pierre, Nobre, Vandack, Oliveira, Carolina F., Shehabi, Yahya, Stolz, Daiana, Verduri, Alessia, Mueller, Beat, & Schuetz, Philipp. (2024). Procalcitonin-guided antibiotic treatment in patients with cancer: a patient-level meta-analysis from randomized controlled trials.
Huynh, Tony, Signal, Dana, & Clinical Endocrinology, 101(6), 580–592. https://doi.org/10.1111/cen.15011
. (2024). Paediatric perspectives in the diagnosis of polyuria-polydipsia syndrome.
Huynh, Tony, Signal, Dana, & Clinical Endocrinology, 101(6), 580–592. https://doi.org/10.1111/cen.15011
. (2024). Paediatric perspectives in the diagnosis of polyuria-polydipsia syndrome.
Karavitaki, Niki, Bettinger, Jeffrey J., Biermasz, Nienke, Endocrine Reviews, 45(6), 773–794. https://doi.org/10.1210/endrev/bnae023
, Gadelha, Monica R, Inder, Warrick J, Tsourdi, Elena, Wakeman, Sarah E., & Zatelli, Maria. (2024). Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement.
Karavitaki, Niki, Bettinger, Jeffrey J., Biermasz, Nienke, Endocrine Reviews, 45(6), 773–794. https://doi.org/10.1210/endrev/bnae023
, Gadelha, Monica R, Inder, Warrick J, Tsourdi, Elena, Wakeman, Sarah E., & Zatelli, Maria. (2024). Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement.
Atila, Cihan, Straumann, Isabelle, Vizeli, Patrick, Beck, Julia, Monnerat, Sophie, Holze, Friederike, Liechti, Matthias E., & JAMA network open, 7(11). https://doi.org/10.1001/jamanetworkopen.2024.45278
. (2024). Oxytocin and the Role of Fluid Restriction in MDMA-Induced Hyponatremia: A Secondary Analysis of 4 Randomized Clinical Trials.
Atila, Cihan, Straumann, Isabelle, Vizeli, Patrick, Beck, Julia, Monnerat, Sophie, Holze, Friederike, Liechti, Matthias E., & JAMA network open, 7(11). https://doi.org/10.1001/jamanetworkopen.2024.45278
. (2024). Oxytocin and the Role of Fluid Restriction in MDMA-Induced Hyponatremia: A Secondary Analysis of 4 Randomized Clinical Trials.
Atila, Cihan, Mekkattu, Shalini, Murugesu, Rakithan, Gaisl, Odile, Varghese, Nimmy, Eckert, Anne, & Endocrine, 86(2), 774–781. https://doi.org/10.1007/s12020-024-03920-2
. (2024). Plasma oxytocin levels in response to glucagon in patients with arginine vasopressin deficiency (central diabetes insipidus) and healthy controls.
Atila, Cihan, Mekkattu, Shalini, Murugesu, Rakithan, Gaisl, Odile, Varghese, Nimmy, Eckert, Anne, & Endocrine, 86(2), 774–781. https://doi.org/10.1007/s12020-024-03920-2
. (2024). Plasma oxytocin levels in response to glucagon in patients with arginine vasopressin deficiency (central diabetes insipidus) and healthy controls.
Bizzozero, Chiara Angela, Monnerat, Sophie, Chapman, Fiona A., Dhaun, Neeraj, Refardt, Julie, & European Journal of Endocrinology, 191(5), 491–498. https://doi.org/10.1093/ejendo/lvae138
. (2024). Apelin levels in patients with polyuria-polydipsia syndrome upon copeptin stimulation tests.
Bizzozero, Chiara Angela, Monnerat, Sophie, Chapman, Fiona A., Dhaun, Neeraj, Refardt, Julie, & European Journal of Endocrinology, 191(5), 491–498. https://doi.org/10.1093/ejendo/lvae138
. (2024). Apelin levels in patients with polyuria-polydipsia syndrome upon copeptin stimulation tests.
Luger, Anton, Durkan, Maeve, European Journal of Endocrinology, 191(5), R71–R77. https://doi.org/10.1093/ejendo/lvae141
, & Marques, Pedro. (2024). European Society of Endocrinology Curriculum and Training Recommendation in Endocrinology.
Luger, Anton, Durkan, Maeve, European Journal of Endocrinology, 191(5), R71–R77. https://doi.org/10.1093/ejendo/lvae141
, & Marques, Pedro. (2024). European Society of Endocrinology Curriculum and Training Recommendation in Endocrinology.
Wälchli-Popovic, Milica, Monnerat, Sophie, Taylor, Angela E., Gilligan, Lorna C., Schiffer, Lina, Arlt, Wiebke, Vogt, Deborah R., De Geyter, Christian, Hutter, Nina, Donath, Marc Y., Sartorius, Gideon, & Frontiers in Endocrinology, 15. https://doi.org/10.3389/fendo.2024.1435698
. (2024). Effects of interleukin-1 receptor antagonism in women with polycystic ovary syndrome—the FertIL trial [Journal-article].
Wälchli-Popovic, Milica, Monnerat, Sophie, Taylor, Angela E., Gilligan, Lorna C., Schiffer, Lina, Arlt, Wiebke, Vogt, Deborah R., De Geyter, Christian, Hutter, Nina, Donath, Marc Y., Sartorius, Gideon, & Frontiers in Endocrinology, 15. https://doi.org/10.3389/fendo.2024.1435698
. (2024). Effects of interleukin-1 receptor antagonism in women with polycystic ovary syndrome—the FertIL trial [Journal-article].
Lamback, E., Filho, F. D. C., Ventura, N., Chimelli, L., Christ-Crain, M., & Gadelha, M. R. (2024). Extraventricular Neurocytoma of the Sellar Region Presenting With Syndrome of Inappropriate Antidiuresis [Journal-article]. JCEM Case Reports, 2(9). https://doi.org/10.1210/jcemcr/luae099
Lamback, E., Filho, F. D. C., Ventura, N., Chimelli, L., Christ-Crain, M., & Gadelha, M. R. (2024). Extraventricular Neurocytoma of the Sellar Region Presenting With Syndrome of Inappropriate Antidiuresis [Journal-article]. JCEM Case Reports, 2(9). https://doi.org/10.1210/jcemcr/luae099
Atila, Cihan, Refardt, Julie, & Nature Reviews Endocrinology, 20(8). https://doi.org/10.1038/s41574-024-00998-6
. (2024). Correction to: Arginine vasopressin deficiency: diagnosis, management and the relevance of oxytocin deficiency (Nature Reviews Endocrinology, (2024), 20, 8, (487-500), 10.1038/s41574-024-00985-x).
Atila, Cihan, Refardt, Julie, & Nature Reviews Endocrinology, 20(8). https://doi.org/10.1038/s41574-024-00998-6
. (2024). Correction to: Arginine vasopressin deficiency: diagnosis, management and the relevance of oxytocin deficiency (Nature Reviews Endocrinology, (2024), 20, 8, (487-500), 10.1038/s41574-024-00985-x).
Atila, Cihan, Refardt, Julie, & Nature Reviews Endocrinology, 20(8), 487–500. https://doi.org/10.1038/s41574-024-00985-x
. (2024). Arginine vasopressin deficiency: diagnosis, management and the relevance of oxytocin deficiency.
Atila, Cihan, Refardt, Julie, & Nature Reviews Endocrinology, 20(8), 487–500. https://doi.org/10.1038/s41574-024-00985-x
. (2024). Arginine vasopressin deficiency: diagnosis, management and the relevance of oxytocin deficiency.
Monnerat, Sophie, Drivakos, Nikolaos, Chapman, Fiona A., Dhaun, Neeraj, Refardt, Julie, & Journal of the Endocrine Society, 8(7). https://doi.org/10.1210/jendso/bvae106
. (2024). Apelin and Copeptin Levels in Patients With Chronic SIAD Treated With Empagliflozin.
Monnerat, Sophie, Drivakos, Nikolaos, Chapman, Fiona A., Dhaun, Neeraj, Refardt, Julie, & Journal of the Endocrine Society, 8(7). https://doi.org/10.1210/jendso/bvae106
. (2024). Apelin and Copeptin Levels in Patients With Chronic SIAD Treated With Empagliflozin.
Fleseriu, M., Christ-Crain, M., Langlois, F., Gadelha, M., & Melmed, S. (2024). Hypopituitarism. The Lancet, 403(10444), 2632–2648. https://doi.org/10.1016/S0140-6736(24)00342-8
Fleseriu, M., Christ-Crain, M., Langlois, F., Gadelha, M., & Melmed, S. (2024). Hypopituitarism. The Lancet, 403(10444), 2632–2648. https://doi.org/10.1016/S0140-6736(24)00342-8
Kriemler, Lilian, Rudin, Salome, Gawinecka, Joanna, Gross, Felix, Arnold, Markus, Schweizer, Juliane, Westphal, Laura, Inauen, Corinne, Pokorny, Thomas, Dittrich, Tolga, Toebak, Anna, Arnold, Marcel, European Stroke Journal, 9(2), 494–500. https://doi.org/10.1177/23969873231221619
, von Eckardstein, Arnold, Rentsch, Katharina, Katan, Mira, & De Marchis, Gian Marco. (2024). Discordance between LDL-C and apolipoprotein B is associated with large-artery-atherosclerosis ischemic stroke in patients ⩽70 years of age.
Kriemler, Lilian, Rudin, Salome, Gawinecka, Joanna, Gross, Felix, Arnold, Markus, Schweizer, Juliane, Westphal, Laura, Inauen, Corinne, Pokorny, Thomas, Dittrich, Tolga, Toebak, Anna, Arnold, Marcel, European Stroke Journal, 9(2), 494–500. https://doi.org/10.1177/23969873231221619
, von Eckardstein, Arnold, Rentsch, Katharina, Katan, Mira, & De Marchis, Gian Marco. (2024). Discordance between LDL-C and apolipoprotein B is associated with large-artery-atherosclerosis ischemic stroke in patients ⩽70 years of age.
Refardt, Julie, Atila, Cihan, & Reviews in Endocrine and Metabolic Disorders, 25(3), 639–649. https://doi.org/10.1007/s11154-023-09862-w
. (2024). New insights on diagnosis and treatment of AVP deficiency.
Refardt, Julie, Atila, Cihan, & Reviews in Endocrine and Metabolic Disorders, 25(3), 639–649. https://doi.org/10.1007/s11154-023-09862-w
. (2024). New insights on diagnosis and treatment of AVP deficiency.
Atila, Cihan, Beck, Julia, Refardt, Julie, Erlic, Zoran, Drummond, Juliana B., Sailer, Clara O., Liechti, Matthias E., Rocha, Beatriz Santana Soares, Beuschlein, Felix, Winzeler, Bettina, & European Journal of Endocrinology, 190(5), 354–362. https://doi.org/10.1093/ejendo/lvae040
. (2024). Psychopathological characteristics in patients with arginine vasopressin deficiency (central diabetes insipidus) and primary polydipsia compared to healthy controls.
Atila, Cihan, Beck, Julia, Refardt, Julie, Erlic, Zoran, Drummond, Juliana B., Sailer, Clara O., Liechti, Matthias E., Rocha, Beatriz Santana Soares, Beuschlein, Felix, Winzeler, Bettina, & European Journal of Endocrinology, 190(5), 354–362. https://doi.org/10.1093/ejendo/lvae040
. (2024). Psychopathological characteristics in patients with arginine vasopressin deficiency (central diabetes insipidus) and primary polydipsia compared to healthy controls.
Lüthi, Hualin, Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Vukajlovic, Tanja, Bologna, Katja, Steinmetz, Michelle, Bathelt, Cemile, Sailer, Clara O., Laager, Mirjam, Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Urwyler, Sandrine A., Kühne, Jill, Baur, Fabienne, Lutz, Linda N., Erlanger, Tobias E., et al. (2024). Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial. eClinicalMedicine, 68. https://doi.org/10.1016/j.eclinm.2024.102429
Lüthi, Hualin, Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Vukajlovic, Tanja, Bologna, Katja, Steinmetz, Michelle, Bathelt, Cemile, Sailer, Clara O., Laager, Mirjam, Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Urwyler, Sandrine A., Kühne, Jill, Baur, Fabienne, Lutz, Linda N., Erlanger, Tobias E., et al. (2024). Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial. eClinicalMedicine, 68. https://doi.org/10.1016/j.eclinm.2024.102429
Lüthi, Hualin, Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Vukajlovic, Tanja, Bologna, Katja, Steinmetz, Michelle, Bathelt, Cemile, Sailer, Clara O., Laager, Mirjam, Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Urwyler, Sandrine A., Kühne, Jill, Baur, Fabienne, Lutz, Linda N., Erlanger, Tobias E., et al. (2024). Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial [Journal-article]. eClinicalMedicine, 68, 102429. https://doi.org/10.1016/j.eclinm.2024.102429
Lüthi, Hualin, Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Vukajlovic, Tanja, Bologna, Katja, Steinmetz, Michelle, Bathelt, Cemile, Sailer, Clara O., Laager, Mirjam, Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Urwyler, Sandrine A., Kühne, Jill, Baur, Fabienne, Lutz, Linda N., Erlanger, Tobias E., et al. (2024). Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial [Journal-article]. eClinicalMedicine, 68, 102429. https://doi.org/10.1016/j.eclinm.2024.102429
Lüthi, Hualin, Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Vukajlovic, Tanja, Bologna, Katja, Steinmetz, Michelle, Bathelt, Cemile, Sailer, Clara O., Laager, Mirjam, Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Urwyler, Sandrine A., Kühne, Jill, Baur, Fabienne, Lutz, Linda N., Erlanger, Tobias E., et al. (2024). Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial [Journal-article]. eClinicalMedicine, 68, 102429. https://doi.org/10.1016/j.eclinm.2024.102429
Lüthi, Hualin, Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Vukajlovic, Tanja, Bologna, Katja, Steinmetz, Michelle, Bathelt, Cemile, Sailer, Clara O., Laager, Mirjam, Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Urwyler, Sandrine A., Kühne, Jill, Baur, Fabienne, Lutz, Linda N., Erlanger, Tobias E., et al. (2024). Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial [Journal-article]. eClinicalMedicine, 68, 102429. https://doi.org/10.1016/j.eclinm.2024.102429
Lüthi, Hualin, Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Vukajlovic, Tanja, Bologna, Katja, Steinmetz, Michelle, Bathelt, Cemile, Sailer, Clara O., Laager, Mirjam, Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Urwyler, Sandrine A., Kühne, Jill, Baur, Fabienne, Lutz, Linda N., Erlanger, Tobias E., et al. (2024). Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial [Journal-article]. eClinicalMedicine, 68, 102429. https://doi.org/10.1016/j.eclinm.2024.102429
Lüthi, Hualin, Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Vukajlovic, Tanja, Bologna, Katja, Steinmetz, Michelle, Bathelt, Cemile, Sailer, Clara O., Laager, Mirjam, Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Urwyler, Sandrine A., Kühne, Jill, Baur, Fabienne, Lutz, Linda N., Erlanger, Tobias E., et al. (2024). Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial [Journal-article]. eClinicalMedicine, 68, 102429. https://doi.org/10.1016/j.eclinm.2024.102429
Refardt, Julie, Vogt, Deborah R., & New England Journal of Medicine, 390(3), 288–290. https://doi.org/10.1056/NEJMc2314326
. (2024). Arginine or Hypertonic Saline-Stimulated Copeptin to Diagnose AVP Deficiency.
Refardt, Julie, Vogt, Deborah R., & New England Journal of Medicine, 390(3), 288–290. https://doi.org/10.1056/NEJMc2314326
. (2024). Arginine or Hypertonic Saline-Stimulated Copeptin to Diagnose AVP Deficiency.
Efthymiadis, Agathoklis, Pofi, Riccardo, Rostom, Hussam, James, Tim, Shine, Brian, Guha, Nish, Cudlip, Simon, Endocrinology, Diabetes and Metabolism, 7(1). https://doi.org/10.1002/edm2.467
, & Pal, Aparna. (2024). Copeptin and the syndrome of inappropriate antidiuresis (SIAD) after pituitary transsphenoidal surgery.
Efthymiadis, Agathoklis, Pofi, Riccardo, Rostom, Hussam, James, Tim, Shine, Brian, Guha, Nish, Cudlip, Simon, Endocrinology, Diabetes and Metabolism, 7(1). https://doi.org/10.1002/edm2.467
, & Pal, Aparna. (2024). Copeptin and the syndrome of inappropriate antidiuresis (SIAD) after pituitary transsphenoidal surgery.
Radvanyi, Z., Yoo, E. J., Kandasamy, P., Salas-Bastos, A., Monnerat, S., Refardt, J., Christ-Crain, M., Hayashi, H., Kondo, Y., Jantsch, J., Rubio-Aliaga, I., Sommer, L., Wagner, C. A., Hediger, M. A., Kwon, H. M., Loffing, J., & Pathare, G. (2024). Extracellular sodium regulates fibroblast growth factor 23 (FGF23) formation [Journal-article]. Journal of Biological Chemistry, 300(1), 105480. https://doi.org/10.1016/j.jbc.2023.105480
Radvanyi, Z., Yoo, E. J., Kandasamy, P., Salas-Bastos, A., Monnerat, S., Refardt, J., Christ-Crain, M., Hayashi, H., Kondo, Y., Jantsch, J., Rubio-Aliaga, I., Sommer, L., Wagner, C. A., Hediger, M. A., Kwon, H. M., Loffing, J., & Pathare, G. (2024). Extracellular sodium regulates fibroblast growth factor 23 (FGF23) formation [Journal-article]. Journal of Biological Chemistry, 300(1), 105480. https://doi.org/10.1016/j.jbc.2023.105480
Rudin, Salome, Kriemler, Lilian, Dittrich, Tolga D., Zietz, Annaelle, Schweizer, Juliane, Arnold, Markus, Peters, Nils, Barinka, Filip, Jung, Simon, Arnold, Marcel, Fischer, Urs, Rentsch, Katharina, Swiss Medical Weekly, 154. https://doi.org/10.57187/s.3633
, Katan, Mira, & De Marchis, Gian Marco. (2024). Lipoprotein(a) as a blood marker for large artery atherosclerosis stroke etiology: validation in a prospective cohort from a swiss stroke center.
Rudin, Salome, Kriemler, Lilian, Dittrich, Tolga D., Zietz, Annaelle, Schweizer, Juliane, Arnold, Markus, Peters, Nils, Barinka, Filip, Jung, Simon, Arnold, Marcel, Fischer, Urs, Rentsch, Katharina, Swiss Medical Weekly, 154. https://doi.org/10.57187/s.3633
, Katan, Mira, & De Marchis, Gian Marco. (2024). Lipoprotein(a) as a blood marker for large artery atherosclerosis stroke etiology: validation in a prospective cohort from a swiss stroke center.
Sterns RH, Rondon-Berrios H, Adrogué HJ, Berl T, Burst V, Cohen DM, Clinical Journal of the American Society of Nephrology, 19(1), 129–135. https://doi.org/10.2215/CJN.0000000000000244
, Cuesta M, Decaux G, Emmett M, Garrahy A, Gankam-Kengne F, Hix JK, Hoorn EJ, Kamel KS, Madias NE, Peri A, Refardt J, Rosner MH, et al. (2024). Treatment Guidelines for Hyponatremia Stay the Course.
Sterns RH, Rondon-Berrios H, Adrogué HJ, Berl T, Burst V, Cohen DM, Clinical Journal of the American Society of Nephrology, 19(1), 129–135. https://doi.org/10.2215/CJN.0000000000000244
, Cuesta M, Decaux G, Emmett M, Garrahy A, Gankam-Kengne F, Hix JK, Hoorn EJ, Kamel KS, Madias NE, Peri A, Refardt J, Rosner MH, et al. (2024). Treatment Guidelines for Hyponatremia Stay the Course.
Baur, Fabienne, Atila, Cihan, Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Bathelt, Cemile, BMJ Nutrition, Prevention and Health, 6(2), 301–309. https://doi.org/10.1136/bmjnph-2023-000781
, & Winzeler, Bettina. (2023). Gender differences in weight gain during attempted and successful smoking cessation on dulaglutide treatment: A predefined secondary analysis of a randomised trial.
Baur, Fabienne, Atila, Cihan, Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Bathelt, Cemile, BMJ Nutrition, Prevention and Health, 6(2), 301–309. https://doi.org/10.1136/bmjnph-2023-000781
, & Winzeler, Bettina. (2023). Gender differences in weight gain during attempted and successful smoking cessation on dulaglutide treatment: A predefined secondary analysis of a randomised trial.
Blum, Claudine A., Roethlisberger, Eva A., Cesana-Nigro, Nicole, Winzeler, Bettina, Rodondi, Nicolas, Blum, Manuel R., Briel, Matthias, Mueller, Beat, BMC Pulmonary Medicine, 23(1). https://doi.org/10.1186/s12890-023-02794-w
, & Schuetz, Philipp. (2023). Adjunct prednisone in community-acquired pneumonia: 180-day outcome of a multicentre, double-blind, randomized, placebo-controlled trial.
Blum, Claudine A., Roethlisberger, Eva A., Cesana-Nigro, Nicole, Winzeler, Bettina, Rodondi, Nicolas, Blum, Manuel R., Briel, Matthias, Mueller, Beat, BMC Pulmonary Medicine, 23(1). https://doi.org/10.1186/s12890-023-02794-w
, & Schuetz, Philipp. (2023). Adjunct prednisone in community-acquired pneumonia: 180-day outcome of a multicentre, double-blind, randomized, placebo-controlled trial.
Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Coynel, David, Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Zanchi, Davide, Erlanger, Tobias E., Trials, 24(1). https://doi.org/10.1186/s13063-023-07164-9
, & Winzeler, Bettina. (2023). Glucagon-like peptide-1 analogues: a new way to quit smoking? (SKIP)—a structured summary of a study protocol for a randomized controlled study.
Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Coynel, David, Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Zanchi, Davide, Erlanger, Tobias E., Trials, 24(1). https://doi.org/10.1186/s13063-023-07164-9
, & Winzeler, Bettina. (2023). Glucagon-like peptide-1 analogues: a new way to quit smoking? (SKIP)—a structured summary of a study protocol for a randomized controlled study.
Sailer CO, Kuehne JM, da Conceição I, Refardt J, Clinical Endocrinology, 99(6), 535–544. https://doi.org/10.1111/cen.14835
, & Winzeler B. (2023). Hypothalamic–pituitary–adrenal axis activity in patients with primary polydipsia compared to healthy controls.
Sailer CO, Kuehne JM, da Conceição I, Refardt J, Clinical Endocrinology, 99(6), 535–544. https://doi.org/10.1111/cen.14835
, & Winzeler B. (2023). Hypothalamic–pituitary–adrenal axis activity in patients with primary polydipsia compared to healthy controls.
Monnerat S, Journal of Clinical Endocrinology and Metabolism, 108(11), Article 11. https://doi.org/10.1210/clinem/dgad217
, & Refardt J. (2023). One Liter a Day, Keeps the Doctor Away (Patent No. 11).
Monnerat S, Journal of Clinical Endocrinology and Metabolism, 108(11), Article 11. https://doi.org/10.1210/clinem/dgad217
, & Refardt J. (2023). One Liter a Day, Keeps the Doctor Away (Patent No. 11).
Smit, J. M., Van Der Zee, P. A., Stoof, S. C. M., Van Genderen, M. E., Snijders, D., Boersma, W. G., Confalonieri, P., Salton, F., Confalonieri, M., Shih, M.-C., Meduri, G. U., Dequin, P.-F., Le Gouge, A., Lloyd, M., Karunajeewa, H., Bartminski, G., Fernández-Serrano, S., Suárez-Cuartín, G., van Klaveren, D., et al. (2023). Predicting individualized treatment effects of corticosteroids in community-acquired-pneumonia: a data-driven analysis of randomized controlled trials [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2023.10.03.23296132
Smit, J. M., Van Der Zee, P. A., Stoof, S. C. M., Van Genderen, M. E., Snijders, D., Boersma, W. G., Confalonieri, P., Salton, F., Confalonieri, M., Shih, M.-C., Meduri, G. U., Dequin, P.-F., Le Gouge, A., Lloyd, M., Karunajeewa, H., Bartminski, G., Fernández-Serrano, S., Suárez-Cuartín, G., van Klaveren, D., et al. (2023). Predicting individualized treatment effects of corticosteroids in community-acquired-pneumonia: a data-driven analysis of randomized controlled trials [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2023.10.03.23296132
Monnerat S, Refardt J, Potasso L, Meier C, & Journal of Clinical Endocrinology and Metabolism, 108(10), e1027–e1033. https://doi.org/10.1210/clinem/dgad238
. (2023). An Increase in Plasma Sodium Levels Is Associated With an Increase in Osteoblast Function in Chronic SIAD.
Monnerat S, Refardt J, Potasso L, Meier C, & Journal of Clinical Endocrinology and Metabolism, 108(10), e1027–e1033. https://doi.org/10.1210/clinem/dgad238
. (2023). An Increase in Plasma Sodium Levels Is Associated With an Increase in Osteoblast Function in Chronic SIAD.
Warren AM, Grossmann M, Endocrine Reviews, 44(5), 819–861. https://doi.org/10.1210/endrev/bnad010
, & Russell N. (2023). Syndrome of Inappropriate Antidiuresis: From Pathophysiology to Management.
Warren AM, Grossmann M, Endocrine Reviews, 44(5), 819–861. https://doi.org/10.1210/endrev/bnad010
, & Russell N. (2023). Syndrome of Inappropriate Antidiuresis: From Pathophysiology to Management.
Potasso, Laura, Monnerat, Sophie, Refardt, Julie, Lindner, Gregor, Burst, Volker, Winzeler, Bettina, & Journal of Clinical Endocrinology and Metabolism, 108(9), 2248–2254. https://doi.org/10.1210/clinem/dgad133
. (2023). Chloride and Potassium Assessment Is a Helpful Tool for Differential Diagnosis of Thiazide-Associated Hyponatremia.
Potasso, Laura, Monnerat, Sophie, Refardt, Julie, Lindner, Gregor, Burst, Volker, Winzeler, Bettina, & Journal of Clinical Endocrinology and Metabolism, 108(9), 2248–2254. https://doi.org/10.1210/clinem/dgad133
. (2023). Chloride and Potassium Assessment Is a Helpful Tool for Differential Diagnosis of Thiazide-Associated Hyponatremia.
Arima H, Cheetham T, Hormone Research in Paediatrics, 96(4), 423–425. https://doi.org/10.1159/000527139
, Cooper DL, Drummond JB, Gurnell M, Levy M, McCormack A, Newell-Price JD, Verbalis JG, & Wass J. (2023). Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group to Consider Renaming Diabetes Insipidus.
Arima H, Cheetham T, Hormone Research in Paediatrics, 96(4), 423–425. https://doi.org/10.1159/000527139
, Cooper DL, Drummond JB, Gurnell M, Levy M, McCormack A, Newell-Price JD, Verbalis JG, & Wass J. (2023). Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group to Consider Renaming Diabetes Insipidus.
Monnerat, Sophie, Atila, Cihan, Baur, Fabienne, de Jesus, Joyce Santos, Refardt, Julie, Dickenmann, Michael, & European Journal of Endocrinology, 189(2), 252–261. https://doi.org/10.1093/ejendo/lvad108
. (2023). Effect of protein supplementation on plasma sodium levels in the syndrome of inappropriate antidiuresis: a monocentric, open-label, proof-of-concept study—the TREASURE study.
Monnerat, Sophie, Atila, Cihan, Baur, Fabienne, de Jesus, Joyce Santos, Refardt, Julie, Dickenmann, Michael, & European Journal of Endocrinology, 189(2), 252–261. https://doi.org/10.1093/ejendo/lvad108
. (2023). Effect of protein supplementation on plasma sodium levels in the syndrome of inappropriate antidiuresis: a monocentric, open-label, proof-of-concept study—the TREASURE study.
Radvanyi, Z., Yoo, E. J., Kandasamy, P., Salas-Bastos, A., Monnerat, S., Refardt, J., Christ-Crain, M., Hayashi, H., Kondo, Y., Jantsch, J., Rubio-Aliaga, I., Sommer, L., Wagner, C. A., Hediger, M. A., Kwon, H. M., Loffing, J., & Pathare, G. (2023). Extracellular sodium regulates fibroblast growth factor 23 (FGF23) formation [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2023.06.23.546282
Radvanyi, Z., Yoo, E. J., Kandasamy, P., Salas-Bastos, A., Monnerat, S., Refardt, J., Christ-Crain, M., Hayashi, H., Kondo, Y., Jantsch, J., Rubio-Aliaga, I., Sommer, L., Wagner, C. A., Hediger, M. A., Kwon, H. M., Loffing, J., & Pathare, G. (2023). Extracellular sodium regulates fibroblast growth factor 23 (FGF23) formation [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2023.06.23.546282
Monnerat S, Atila C, Refardt J, & Journal of the Endocrine Society, 7(4), bvad011. https://doi.org/10.1210/jendso/bvad011
. (2023). Prevalence of Admission Hyponatremia in Patients With Diabetes Treated With and Without an SGLT2 inhibitor.
Monnerat S, Atila C, Refardt J, & Journal of the Endocrine Society, 7(4), bvad011. https://doi.org/10.1210/jendso/bvad011
. (2023). Prevalence of Admission Hyponatremia in Patients With Diabetes Treated With and Without an SGLT2 inhibitor.
Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Vukajlovic, Tanja, Bologna, Katja, Steinmetz, Michelle, Bathelt, Cemile, Sailer, Clara O., Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Urwyler, Sandrine A., Kühne, Jill, Baur, Fabienne, Lutz, Linda N., Erlanger, Tobias E., eClinicalMedicine, 57. https://doi.org/10.1016/j.eclinm.2023.101865
, & Winzeler, Bettina. (2023). Effect of dulaglutide in promoting abstinence during smoking cessation: a single-centre, randomized, double-blind, placebo-controlled, parallel group trial.
Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Vukajlovic, Tanja, Bologna, Katja, Steinmetz, Michelle, Bathelt, Cemile, Sailer, Clara O., Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Urwyler, Sandrine A., Kühne, Jill, Baur, Fabienne, Lutz, Linda N., Erlanger, Tobias E., eClinicalMedicine, 57. https://doi.org/10.1016/j.eclinm.2023.101865
, & Winzeler, Bettina. (2023). Effect of dulaglutide in promoting abstinence during smoking cessation: a single-centre, randomized, double-blind, placebo-controlled, parallel group trial.
Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Vukajlovic, Tanja, Bologna, Katja, Steinmetz, Michelle, Bathelt, Cemile, Sailer, Clara O., Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Urwyler, Sandrine A., Kühne, Jill, Baur, Fabienne, Lutz, Linda N., Erlanger, Tobias E., eClinicalMedicine, 57, 101865. https://doi.org/10.1016/j.eclinm.2023.101865
, & Winzeler, Bettina. (2023). Effect of dulaglutide in promoting abstinence during smoking cessation: a single-centre, randomized, double-blind, placebo-controlled, parallel group trial [Journal-article].
Lengsfeld, Sophia, Burkard, Thilo, Meienberg, Andrea, Jeanloz, Nica, Vukajlovic, Tanja, Bologna, Katja, Steinmetz, Michelle, Bathelt, Cemile, Sailer, Clara O., Vogt, Deborah R., Hemkens, Lars G., Speich, Benjamin, Urwyler, Sandrine A., Kühne, Jill, Baur, Fabienne, Lutz, Linda N., Erlanger, Tobias E., eClinicalMedicine, 57, 101865. https://doi.org/10.1016/j.eclinm.2023.101865
, & Winzeler, Bettina. (2023). Effect of dulaglutide in promoting abstinence during smoking cessation: a single-centre, randomized, double-blind, placebo-controlled, parallel group trial [Journal-article].
Pelouto A, Refardt JC, European Journal of Endocrinology, 188(3), 322–330. https://doi.org/10.1093/ejendo/lvad028
, Zandbergen AAM, & Hoorn EJ. (2023). Overcorrection and undercorrection with fixed dosing of bolus hypertonic saline for symptomatic hyponatremia.
Pelouto A, Refardt JC, European Journal of Endocrinology, 188(3), 322–330. https://doi.org/10.1093/ejendo/lvad028
, Zandbergen AAM, & Hoorn EJ. (2023). Overcorrection and undercorrection with fixed dosing of bolus hypertonic saline for symptomatic hyponatremia.
Sailer CO, Gaisl O, Beglinger S, Frech-Dörfler M, Sommer V, Lüthy MH, & European Journal of Endocrinology, 188(3), 266–272. https://doi.org/10.1093/ejendo/lvad022
. (2023). Copeptin improves prediction of treatment response in children with monosymptomatic nocturnal enuresis.
Sailer CO, Gaisl O, Beglinger S, Frech-Dörfler M, Sommer V, Lüthy MH, & European Journal of Endocrinology, 188(3), 266–272. https://doi.org/10.1093/ejendo/lvad022
. (2023). Copeptin improves prediction of treatment response in children with monosymptomatic nocturnal enuresis.
Workeneh BT, Meena P, Advances in Kidney Disease and Health , 30(2), 85–101. https://doi.org/10.1053/j.akdh.2022.11.004
, & Rondon-Berrios H. (2023). Hyponatremia Demystified: Integrating Physiology to Shape Clinical Practice.
Workeneh BT, Meena P, Advances in Kidney Disease and Health , 30(2), 85–101. https://doi.org/10.1053/j.akdh.2022.11.004
, & Rondon-Berrios H. (2023). Hyponatremia Demystified: Integrating Physiology to Shape Clinical Practice.
Refardt J, Imber C, Nobbenhuis R, Sailer CO, Haslbauer A, Monnerat S, Bathelt C, Vogt DR, Berres M, Winzeler B, Bridenbaugh SA, & Journal of the American Society of Nephrology, 34(2), 322–332. https://doi.org/10.1681/ASN.2022050623
. (2023). Treatment Effect of the SGLT2 Inhibitor Empagliflozin on Chronic Syndrome of Inappropriate Antidiuresis: Results of a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
Refardt J, Imber C, Nobbenhuis R, Sailer CO, Haslbauer A, Monnerat S, Bathelt C, Vogt DR, Berres M, Winzeler B, Bridenbaugh SA, & Journal of the American Society of Nephrology, 34(2), 322–332. https://doi.org/10.1681/ASN.2022050623
. (2023). Treatment Effect of the SGLT2 Inhibitor Empagliflozin on Chronic Syndrome of Inappropriate Antidiuresis: Results of a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
Arima H, Cheetham T, Journal of Clinical Endocrinology and Metabolism, 108(1), 1–3. https://doi.org/10.1210/clinem/dgac547
, Cooper D, Drummond J, Gurnell M, Levy M, McCormack A, Newell-Price J, Verbalis JG, Wass J, & Working Group for Renaming Diabetes Insipidus. (2023). Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus.
Arima H, Cheetham T, Journal of Clinical Endocrinology and Metabolism, 108(1), 1–3. https://doi.org/10.1210/clinem/dgac547
, Cooper D, Drummond J, Gurnell M, Levy M, McCormack A, Newell-Price J, Verbalis JG, Wass J, & Working Group for Renaming Diabetes Insipidus. (2023). Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus.
Atila, Cihan, Holze, Friederike, Murugesu, Rakithan, Rommers, Nikki, Hutter, Nina, Varghese, Nimmy, Sailer, Clara O, Eckert, Anne, Heinrichs, Markus, Liechti, Matthias E, & The Lancet Diabetes and Endocrinology, 11, 454–464. https://doi.org/10.1016/S2213-8587(23)00120-1
. (2023). Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case-control study with nested, randomised, double-blind, placebo-controlled crossover trial.
Atila, Cihan, Holze, Friederike, Murugesu, Rakithan, Rommers, Nikki, Hutter, Nina, Varghese, Nimmy, Sailer, Clara O, Eckert, Anne, Heinrichs, Markus, Liechti, Matthias E, & The Lancet Diabetes and Endocrinology, 11, 454–464. https://doi.org/10.1016/S2213-8587(23)00120-1
. (2023). Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case-control study with nested, randomised, double-blind, placebo-controlled crossover trial.
Probst, L., Monnerat, S., Vogt, D. R., Lengsfeld, S., Burkard, T., Meienberg, A., Bathelt, C., Christ-Crain, M., & Winzeler, B. (2023). Effects of dulaglutide on alcohol consumption during smoking cessation. JCI Insight, 8(22). https://doi.org/10.1172/jci.insight.170419
Probst, L., Monnerat, S., Vogt, D. R., Lengsfeld, S., Burkard, T., Meienberg, A., Bathelt, C., Christ-Crain, M., & Winzeler, B. (2023). Effects of dulaglutide on alcohol consumption during smoking cessation. JCI Insight, 8(22). https://doi.org/10.1172/jci.insight.170419
Roth, Sofia, Flint, Emilio, Ghataore, Lea, Patel, Vishal C., Singanayagam, Arjuna, Vincent, Royce P., Triantafyllou, Evangelos, Ma, Yun, Bernal, William, Auzinger, Georg, Heneghan, Michael, Antoniades, Charalambos, Gastro Hep Advances, 2(1), 72–82. https://doi.org/10.1016/j.gastha.2022.08.006
, McPhail, Mark J.W., Taylor, David R., Wendon, Julia, & Bernsmeier, Christine. (2023). Low Baseline but Not Delta Cortisol Relates to 28-Day Transplant-Free Survival in Acute and Acute-on-Chronic Liver Failure.
Roth, Sofia, Flint, Emilio, Ghataore, Lea, Patel, Vishal C., Singanayagam, Arjuna, Vincent, Royce P., Triantafyllou, Evangelos, Ma, Yun, Bernal, William, Auzinger, Georg, Heneghan, Michael, Antoniades, Charalambos, Gastro Hep Advances, 2(1), 72–82. https://doi.org/10.1016/j.gastha.2022.08.006
, McPhail, Mark J.W., Taylor, David R., Wendon, Julia, & Bernsmeier, Christine. (2023). Low Baseline but Not Delta Cortisol Relates to 28-Day Transplant-Free Survival in Acute and Acute-on-Chronic Liver Failure.
Arima H, Bichet DG, Cheetham T, Pituitary, 25(6), Article 6. https://doi.org/10.1007/s11102-022-01276-2
, Drummond J, Gurnell M, Levy M, McCormack A, Newell-Price J, Verbalis JG, Wass J, & Cooper D. (2022). Changing the name of diabetes insipidus (Patent No. 6).
Arima H, Bichet DG, Cheetham T, Pituitary, 25(6), Article 6. https://doi.org/10.1007/s11102-022-01276-2
, Drummond J, Gurnell M, Levy M, McCormack A, Newell-Price J, Verbalis JG, Wass J, & Cooper D. (2022). Changing the name of diabetes insipidus (Patent No. 6).
Borisov AN, Blum CA, Nutrition and Diabetes, 12(1), 12. https://doi.org/10.1038/s41387-022-00190-7
, & Ebrahimi F. (2022). No obesity paradox in patients with community-acquired pneumonia – secondary analysis of a randomized controlled trial.
Borisov AN, Blum CA, Nutrition and Diabetes, 12(1), 12. https://doi.org/10.1038/s41387-022-00190-7
, & Ebrahimi F. (2022). No obesity paradox in patients with community-acquired pneumonia – secondary analysis of a randomized controlled trial.
Liberale, Luca, Ministrini, Stefano, Arnold, Markus, Puspitasari, Yustina M., Pokorny, Thomas, Beer, Georgia, Scherrer, Natalie, Schweizer, Juliane, Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-23211-y
, Montecucco, Fabrizio, Camici, Giovanni G., & Katan Kahles, Mira. (2022). Serum circulating sirtuin 6 as a novel predictor of mortality after acute ischemic stroke.
Liberale, Luca, Ministrini, Stefano, Arnold, Markus, Puspitasari, Yustina M., Pokorny, Thomas, Beer, Georgia, Scherrer, Natalie, Schweizer, Juliane, Scientific Reports, 12(1). https://doi.org/10.1038/s41598-022-23211-y
, Montecucco, Fabrizio, Camici, Giovanni G., & Katan Kahles, Mira. (2022). Serum circulating sirtuin 6 as a novel predictor of mortality after acute ischemic stroke.
Nahum U, Refardt J, Chifu I, Fenske WK, Fassnacht M, Szinnai G, European Journal of Endocrinology, 187(6), 777–786. https://doi.org/10.1530/EJE-22-0368
, & Pfister M. (2022). Machine learning-based algorithm as an innovative approach for the differentiation between diabetes insipidus and primary polydipsia in clinical practice.
Nahum U, Refardt J, Chifu I, Fenske WK, Fassnacht M, Szinnai G, European Journal of Endocrinology, 187(6), 777–786. https://doi.org/10.1530/EJE-22-0368
, & Pfister M. (2022). Machine learning-based algorithm as an innovative approach for the differentiation between diabetes insipidus and primary polydipsia in clinical practice.
Working Group for Renaming Diabetes Insipidus, Arima H, Cheetham T, Endocrine Connections, 11(11). https://doi.org/10.1530/EC-22-0378
, Cooper D, Gurnell M, Drummond JB, Levy M, McCormack AI, Verbalis J, Newell-Price J, & Wass JAH. (2022). Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus.
Working Group for Renaming Diabetes Insipidus, Arima H, Cheetham T, Endocrine Connections, 11(11). https://doi.org/10.1530/EC-22-0378
, Cooper D, Gurnell M, Drummond JB, Levy M, McCormack AI, Verbalis J, Newell-Price J, & Wass JAH. (2022). Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus.
Working Group for Renaming Diabetes Insipidus, Arima H, Cheetham T, European Journal of Endocrinology, 187(5), P1–P3. https://doi.org/10.1530/EJE-22-0751
, Cooper D, Gurnell M, Drummond JB, Levy M, McCormack AI, Verbalis J, Newell-Price J, & Wass JAH. (2022). Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus.
Working Group for Renaming Diabetes Insipidus, Arima H, Cheetham T, European Journal of Endocrinology, 187(5), P1–P3. https://doi.org/10.1530/EJE-22-0751
, Cooper D, Gurnell M, Drummond JB, Levy M, McCormack AI, Verbalis J, Newell-Price J, & Wass JAH. (2022). Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus.
Atila C, Loughrey PB, Garrahy A, Winzeler B, Refardt J, Gildroy P, Hamza M., Pal A, Verbalis JG, Thompson CJ, Hemkens L.G., Hunter SJ, Sherlock M, Levy MJ, Karavitaki N., Newell-Price J, Wass JAH, & The Lancet Diabetes and Endocrinology, 10(10), 700–709. https://doi.org/10.1016/S2213-8587(22)00219-4
. (2022). Central diabetes insipidus from a patient’s perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey.
Atila C, Loughrey PB, Garrahy A, Winzeler B, Refardt J, Gildroy P, Hamza M., Pal A, Verbalis JG, Thompson CJ, Hemkens L.G., Hunter SJ, Sherlock M, Levy MJ, Karavitaki N., Newell-Price J, Wass JAH, & The Lancet Diabetes and Endocrinology, 10(10), 700–709. https://doi.org/10.1016/S2213-8587(22)00219-4
. (2022). Central diabetes insipidus from a patient’s perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey.
Arima H, Cheetham T, Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus. https://doi.org/10.1111/cen.14819
, Cooper D, Drummond J, Gurnell M, Levy M, McCormack A, Newell-Price J, Verbalis JG, & Wass J. (2022, August 28).
Arima H, Cheetham T, Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus. https://doi.org/10.1111/cen.14819
, Cooper D, Drummond J, Gurnell M, Levy M, McCormack A, Newell-Price J, Verbalis JG, & Wass J. (2022, August 28).
Atila C, Monnerat S, Urwyler SA, Refardt J, Winzeler B, & Pituitary, 25(4), 636–644. https://doi.org/10.1007/s11102-022-01240-0
. (2022). The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults: Data from: Glucacop, Macicop, and CARGO study.
Atila C, Monnerat S, Urwyler SA, Refardt J, Winzeler B, & Pituitary, 25(4), 636–644. https://doi.org/10.1007/s11102-022-01240-0
. (2022). The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults: Data from: Glucacop, Macicop, and CARGO study.
Atila C, Gaisl O, Vogt DR, Werlen L, Szinnai G, & European Journal of Endocrinology, 187(1), 65–74. https://doi.org/10.1530/EJE-22-0033
. (2022). Glucagon-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a double-blind, randomized, placebo-controlled study.
Atila C, Gaisl O, Vogt DR, Werlen L, Szinnai G, & European Journal of Endocrinology, 187(1), 65–74. https://doi.org/10.1530/EJE-22-0033
. (2022). Glucagon-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a double-blind, randomized, placebo-controlled study.
Bicvic A, Scherrer N, Schweizer J, Fluri F, European Stroke Journal, 7(2), 158–165. https://doi.org/10.1177/23969873221090798
, De Marchis GM, Luft AR, & Katan M. (2022). A novel biomarker panel index improves risk stratification after ischemic stroke.
Bicvic A, Scherrer N, Schweizer J, Fluri F, European Stroke Journal, 7(2), 158–165. https://doi.org/10.1177/23969873221090798
, De Marchis GM, Luft AR, & Katan M. (2022). A novel biomarker panel index improves risk stratification after ischemic stroke.
Journal of Clinical Endocrinology and Metabolism, 107(6), 1727–1738. https://doi.org/10.1210/clinem/dgac070
, Refardt J, & Winzeler B. (2022). Approach to the Patient: “Utility of the Copeptin Assay”.
Journal of Clinical Endocrinology and Metabolism, 107(6), 1727–1738. https://doi.org/10.1210/clinem/dgac070
, Refardt J, & Winzeler B. (2022). Approach to the Patient: “Utility of the Copeptin Assay”.
Vukajlovic T, Sailer CO, Asmar A, Jensen BL, Vogt DR, Journal of Clinical Endocrinology and Metabolism, 107(6), E2581–E2589. https://doi.org/10.1210/clinem/dgac063
, & Winzeler B. (2022). Effect of a 3-Week Treatment with GLP-1 Receptor Agonists on Vasoactive Hormones in Euvolemic Participants.
Vukajlovic T, Sailer CO, Asmar A, Jensen BL, Vogt DR, Journal of Clinical Endocrinology and Metabolism, 107(6), E2581–E2589. https://doi.org/10.1210/clinem/dgac063
, & Winzeler B. (2022). Effect of a 3-Week Treatment with GLP-1 Receptor Agonists on Vasoactive Hormones in Euvolemic Participants.
Atila, C., Monnerat, S., Urwyler, S. A., Refardt, J., Winzeler, B., & Christ-Crain, M. (2022, May 12). The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults [Posted-content]. Research Square Platform LLC. https://doi.org/10.21203/rs.3.rs-1636018/v1
Atila, C., Monnerat, S., Urwyler, S. A., Refardt, J., Winzeler, B., & Christ-Crain, M. (2022, May 12). The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults [Posted-content]. Research Square Platform LLC. https://doi.org/10.21203/rs.3.rs-1636018/v1
Sailer, C. O., Kühne, J. M., Conceição, I. d., Refardt, J., Christ-Crain, M., & Winzeler, B. (2022, March 3). Hypothalamic-pituitary-adrenal axis activity in patients with primary polydipsia compared to healthy volunteers [Posted-content]. Research Square Platform LLC. https://doi.org/10.21203/rs.3.rs-1370576/v1
Sailer, C. O., Kühne, J. M., Conceição, I. d., Refardt, J., Christ-Crain, M., & Winzeler, B. (2022, March 3). Hypothalamic-pituitary-adrenal axis activity in patients with primary polydipsia compared to healthy volunteers [Posted-content]. Research Square Platform LLC. https://doi.org/10.21203/rs.3.rs-1370576/v1
Potasso, Laura, Refardt, Julie, De Marchis, Gian Marco, Wiencierz, Andrea, Wright, Patrick R, Wagner, Benjamin, Dittrich, Tolga, Polymeris, Alexandros A, Gensicke, Henrik, Bonati, Leo H, & Journal of Clinical Endocrinology and Metabolism, 107(2), E672–E680. https://doi.org/10.1210/clinem/dgab650
. (2022). Impact of Sodium Levels on Functional Outcomes in Patients with Stroke - A Swiss Stroke Registry Analysis.
Potasso, Laura, Refardt, Julie, De Marchis, Gian Marco, Wiencierz, Andrea, Wright, Patrick R, Wagner, Benjamin, Dittrich, Tolga, Polymeris, Alexandros A, Gensicke, Henrik, Bonati, Leo H, & Journal of Clinical Endocrinology and Metabolism, 107(2), E672–E680. https://doi.org/10.1210/clinem/dgab650
. (2022). Impact of Sodium Levels on Functional Outcomes in Patients with Stroke - A Swiss Stroke Registry Analysis.
Potasso L, Refardt J, De Marchis GM, Wiencierz A, Wright PR, Wagner B, Dittrich T, Polymeris AA, Gensicke H, Bonati LH, & Journal of Clinical Endocrinology and Metabolism, 107(2), E672–E680. https://doi.org/10.1210/clinem/dgab650
. (2022). Impact of Sodium Levels on Functional Outcomes in Patients with Stroke - A Swiss Stroke Registry Analysis.
Potasso L, Refardt J, De Marchis GM, Wiencierz A, Wright PR, Wagner B, Dittrich T, Polymeris AA, Gensicke H, Bonati LH, & Journal of Clinical Endocrinology and Metabolism, 107(2), E672–E680. https://doi.org/10.1210/clinem/dgab650
. (2022). Impact of Sodium Levels on Functional Outcomes in Patients with Stroke - A Swiss Stroke Registry Analysis.
Tritos NA, Fazeli PK, McCormack A, Mallea-Gil SM, Pineyro MM, Pituitary, 25(1), 64–73. https://doi.org/10.1007/s11102-021-01170-3
, Frara S, Labadzhyan A, Ioachimescu AG, Shimon I, Takahashi Y, Gurnell M, Fleseriu M, & “Pituitary Society Delphi Collaborative Group”. (2022). Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas.
Tritos NA, Fazeli PK, McCormack A, Mallea-Gil SM, Pineyro MM, Pituitary, 25(1), 64–73. https://doi.org/10.1007/s11102-021-01170-3
, Frara S, Labadzhyan A, Ioachimescu AG, Shimon I, Takahashi Y, Gurnell M, Fleseriu M, & “Pituitary Society Delphi Collaborative Group”. (2022). Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas.
Arima H, Cheetham T, Archives of Endocrinology and Metabolism, 66, 868–870. https://doi.org/10.20945/2359-3997000000528
, Cooper DL, Drummond JB, Gurnell M, Levy M, McCormack A, Newell-Price JD, Verbalis JG, & Wass J. (2022). Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus.
Arima H, Cheetham T, Archives of Endocrinology and Metabolism, 66, 868–870. https://doi.org/10.20945/2359-3997000000528
, Cooper DL, Drummond JB, Gurnell M, Levy M, McCormack A, Newell-Price JD, Verbalis JG, & Wass J. (2022). Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus.
Atila C, Monnerat S, Bingisser R, Siegemund M, Lampart M, Rueegg M, Zellweger N, Osswald S, Rentsch K, Endocrine Connections, 11(10). https://doi.org/10.1530/EC-22-0171
, & Twerenbold R. (2022). Inverse relationship between IL-6 and sodium levels in patients with COVID-19 and other respiratory tract infections: data from the COVIVA study.
Atila C, Monnerat S, Bingisser R, Siegemund M, Lampart M, Rueegg M, Zellweger N, Osswald S, Rentsch K, Endocrine Connections, 11(10). https://doi.org/10.1530/EC-22-0171
, & Twerenbold R. (2022). Inverse relationship between IL-6 and sodium levels in patients with COVID-19 and other respiratory tract infections: data from the COVIVA study.
Potasso L, Potasso L, Refardt J., Meier C, & European Journal of Endocrinology, 186(1), 1–8. https://doi.org/10.1530/EJE-21-0604
(2022). Effect of hyponatremia normalization on osteoblast function in patients with SIAD.
Potasso L, Potasso L, Refardt J., Meier C, & European Journal of Endocrinology, 186(1), 1–8. https://doi.org/10.1530/EJE-21-0604
(2022). Effect of hyponatremia normalization on osteoblast function in patients with SIAD.
Wittermans E, van der Zee PA, Qi H., van de Garde EMW, Blum CA, ERJ Open Research, 8(1). https://doi.org/10.1183/23120541.00489-2021
, Gommers D, Grutters JC, Voorn GP, Bos WJW, & Endeman H. (2022). Community-acquired pneumonia subgroups and differential response to corticosteroids: a secondary analysis of controlled studies.
Wittermans E, van der Zee PA, Qi H., van de Garde EMW, Blum CA, ERJ Open Research, 8(1). https://doi.org/10.1183/23120541.00489-2021
, Gommers D, Grutters JC, Voorn GP, Bos WJW, & Endeman H. (2022). Community-acquired pneumonia subgroups and differential response to corticosteroids: a secondary analysis of controlled studies.
Working Group for Renaming Diabetes Insipidus, Arima H, Cheetham T, Endocrine Journal, 69(11), 1281–1284. https://doi.org/10.1507/endocrj.EJ20220831
, Cooper D, Gurnell M, Drummond JB, Levy M, McCormack AI, Verbalis J, Newell-Price J, & Wass JAH. (2022). Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus.
Working Group for Renaming Diabetes Insipidus, Arima H, Cheetham T, Endocrine Journal, 69(11), 1281–1284. https://doi.org/10.1507/endocrj.EJ20220831
, Cooper D, Gurnell M, Drummond JB, Levy M, McCormack AI, Verbalis J, Newell-Price J, & Wass JAH. (2022). Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus.
Berkmann S, Roethlisberger M, Mueller B, Pituitary, 24(6), 878–886. https://doi.org/10.1007/s11102-021-01160-5
, Mariani L., Nitzsche E, & Juengling F. (2021). Selective resection of cushing microadenoma guided by preoperative hybrid 18-fluoroethyl-L-tyrosine and 11-C-methionine PET/MRI.
Berkmann S, Roethlisberger M, Mueller B, Pituitary, 24(6), 878–886. https://doi.org/10.1007/s11102-021-01160-5
, Mariani L., Nitzsche E, & Juengling F. (2021). Selective resection of cushing microadenoma guided by preoperative hybrid 18-fluoroethyl-L-tyrosine and 11-C-methionine PET/MRI.
Presse Medicale, 50(4), 104093. https://doi.org/10.1016/j.lpm.2021.104093
, & Gaisl O. (2021). Diabetes insipidus.
Presse Medicale, 50(4), 104093. https://doi.org/10.1016/j.lpm.2021.104093
, & Gaisl O. (2021). Diabetes insipidus.
Ebrahimi, Fahim, Urwyler, Sandrine Andrea, Betz, Matthias Johannes, Christ, Emanuel Remigius, Schuetz, Philipp, Müller, Beat, Donath, Marc Yves, & Scientific Reports, 11(1), 7911. https://doi.org/10.1038/s41598-021-87207-w
. (2021). Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndrome.
Ebrahimi, Fahim, Urwyler, Sandrine Andrea, Betz, Matthias Johannes, Christ, Emanuel Remigius, Schuetz, Philipp, Müller, Beat, Donath, Marc Yves, & Scientific Reports, 11(1), 7911. https://doi.org/10.1038/s41598-021-87207-w
. (2021). Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndrome.
Ebrahimi F., Urwyler S.A., Betz M.J., Christ E.R., Schuetz P., Mueller B., Donath M.Y., & Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-87207-w
(2021). Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndrome.
Ebrahimi F., Urwyler S.A., Betz M.J., Christ E.R., Schuetz P., Mueller B., Donath M.Y., & Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-87207-w
(2021). Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndrome.
Sailer C.O., Refardt J, Blum CA, Schnyder I, Molina-Tijeras J.A., Fenske W., Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-89505-9
, & (2021). Validity of different copeptin assays in the differential diagnosis of the polyuria-polydipsia syndrome.
Sailer C.O., Refardt J, Blum CA, Schnyder I, Molina-Tijeras J.A., Fenske W., Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-89505-9
, & (2021). Validity of different copeptin assays in the differential diagnosis of the polyuria-polydipsia syndrome.
Raess N., Schuetz P., Cesana-Nigro N., Winzeler B, Urwyler SA, Schaedelin S., Rodondi N, Blum M.R., Briel M., Mueller B, Journal of Clinical Pharmacology, 61(11), 1406–1414. https://doi.org/10.1002/jcph.1914
, & Blum CA. (2021). Influence of Prednisone on Inflammatory Biomarkers in Community-Acquired Pneumonia: Secondary Analysis of a Randomized Trial.
Raess N., Schuetz P., Cesana-Nigro N., Winzeler B, Urwyler SA, Schaedelin S., Rodondi N, Blum M.R., Briel M., Mueller B, Journal of Clinical Pharmacology, 61(11), 1406–1414. https://doi.org/10.1002/jcph.1914
, & Blum CA. (2021). Influence of Prednisone on Inflammatory Biomarkers in Community-Acquired Pneumonia: Secondary Analysis of a Randomized Trial.
Refardt J, Pelouto A, Potasso L, Hoorn EJ, & Frontiers in Medicine, 8, 729545. https://doi.org/10.3389/fmed.2021.729545
. (2021). Hyponatremia Intervention Trial (HIT): Study Protocol of a Randomized, Controlled, Parallel-Group Trial With Blinded Outcome Assessment.
Refardt J, Pelouto A, Potasso L, Hoorn EJ, & Frontiers in Medicine, 8, 729545. https://doi.org/10.3389/fmed.2021.729545
. (2021). Hyponatremia Intervention Trial (HIT): Study Protocol of a Randomized, Controlled, Parallel-Group Trial With Blinded Outcome Assessment.
Heilmann E., Gregoriano C., Annane D., Reinhart K., Bouadma L., Wolff M., Chastre J., Luyt C.-E., Tubach F., Branche A.R., Briel M., Age and Ageing, 50(5), 1546–1556. https://doi.org/10.1093/ageing/afab078
, Welte T., Corti C., De Jong E., Nijsten M., De Lange D.W., Van Oers J.A.H., Beishuizen A., et al. (2021). Duration of antibiotic treatment using procalcitonin-guided treatment algorithms in older patients: A patient-level meta-analysis from randomized controlled trials.
Heilmann E., Gregoriano C., Annane D., Reinhart K., Bouadma L., Wolff M., Chastre J., Luyt C.-E., Tubach F., Branche A.R., Briel M., Age and Ageing, 50(5), 1546–1556. https://doi.org/10.1093/ageing/afab078
, Welte T., Corti C., De Jong E., Nijsten M., De Lange D.W., Van Oers J.A.H., Beishuizen A., et al. (2021). Duration of antibiotic treatment using procalcitonin-guided treatment algorithms in older patients: A patient-level meta-analysis from randomized controlled trials.
Sailer C.O., Winzeler B, Urwyler SA, Schnyder I., Refardt J, Eckert A., Varghese N., Fassnacht M., Chifu I., Lawson E.A., Verbalis J.G., Fenske W., & European Journal of Endocrinology, 185(3), 355–364. https://doi.org/10.1530/EJE-21-0346
. (2021). Oxytocin levels in response to pituitary provocation tests in healthy volunteers.
Sailer C.O., Winzeler B, Urwyler SA, Schnyder I., Refardt J, Eckert A., Varghese N., Fassnacht M., Chifu I., Lawson E.A., Verbalis J.G., Fenske W., & European Journal of Endocrinology, 185(3), 355–364. https://doi.org/10.1530/EJE-21-0346
. (2021). Oxytocin levels in response to pituitary provocation tests in healthy volunteers.
ENDOCRINOLOGY IN THE TIME OF COVID-19-2021 UPDATES: The management of diabetes insipidus and hyponatraemia. (Patent No. 4). 185(4), Article 4. https://doi.org/10.1530/eje-21-0596
, Hoorn EJ, Sherlock M, Thompson CJ, & Wass J. (2021).
ENDOCRINOLOGY IN THE TIME OF COVID-19-2021 UPDATES: The management of diabetes insipidus and hyponatraemia. (Patent No. 4). 185(4), Article 4. https://doi.org/10.1530/eje-21-0596
, Hoorn EJ, Sherlock M, Thompson CJ, & Wass J. (2021).
Urwyler SA, Lustenberger S, Drummond JR, Soares BS, Vogt DR, Ammer N, Yuen KCJ, Ribeiro-Oliveira A, & Pituitary, 24(4), 555–563. https://doi.org/10.1007/s11102-021-01132-9
. (2021). Effects of oral macimorelin on copeptin and anterior pituitary hormones in healthy volunteers.
Urwyler SA, Lustenberger S, Drummond JR, Soares BS, Vogt DR, Ammer N, Yuen KCJ, Ribeiro-Oliveira A, & Pituitary, 24(4), 555–563. https://doi.org/10.1007/s11102-021-01132-9
. (2021). Effects of oral macimorelin on copeptin and anterior pituitary hormones in healthy volunteers.
Journal of Internal Medicine, 290(1), 73–87. https://doi.org/10.1111/joim.13261
, Winzeler B, & Refardt J. (2021). Diagnosis and management of diabetes insipidus for the internist: an update.
Journal of Internal Medicine, 290(1), 73–87. https://doi.org/10.1111/joim.13261
, Winzeler B, & Refardt J. (2021). Diagnosis and management of diabetes insipidus for the internist: an update.
Tsagkas C, Schäfer S, Baumgartner A, Müller J, Sinnecker T, Mehling M, van der Stouwe JG, Felder S, Panagiotou A, Potlukova E, Winzeler B, Scholz MC, Timper K, Blackham K, Nickel CH, The Lancet, 397(10290), 2194. https://doi.org/10.1016/S0140-6736(21)00986-7
, Bingisser R, Lyrer P, Kappos L, & Yaldizli Ö. (2021). Syndrome of inappropriate antidiuretic hormone secretion and hypothalamic hypocortisolism in neuromyelitis optica.
Tsagkas C, Schäfer S, Baumgartner A, Müller J, Sinnecker T, Mehling M, van der Stouwe JG, Felder S, Panagiotou A, Potlukova E, Winzeler B, Scholz MC, Timper K, Blackham K, Nickel CH, The Lancet, 397(10290), 2194. https://doi.org/10.1016/S0140-6736(21)00986-7
, Bingisser R, Lyrer P, Kappos L, & Yaldizli Ö. (2021). Syndrome of inappropriate antidiuretic hormone secretion and hypothalamic hypocortisolism in neuromyelitis optica.
Fischli S, Von Wyl V., Wuillemin W., Von Kanel R., Schütz P, Journal of the Endocrine Society, 5(5). https://doi.org/10.1210/jendso/bvab047
, Studer F., Brander L., Schupfer G., Metzger J, & Henzen C. (2021). Impact of adrenal function on Hemostasis/Endothelial function in patients undergoing surgery.
Fischli S, Von Wyl V., Wuillemin W., Von Kanel R., Schütz P, Journal of the Endocrine Society, 5(5). https://doi.org/10.1210/jendso/bvab047
, Studer F., Brander L., Schupfer G., Metzger J, & Henzen C. (2021). Impact of adrenal function on Hemostasis/Endothelial function in patients undergoing surgery.
Stormann S., Schopohl J., Bullmann C., Terkamp C., Experimental and Clinical Endocrinology and Diabetes, 129(3), 224–233. https://doi.org/10.1055/a-1247-4713
, Finke R., Flitsch J., Kreitschmann-Andermahr I., Luger A., Stalla G., Houchard A., Helbig D., & Petersenn S. (2021). Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Acromegaly in Routine Clinical Practice in Germany, Austria and Switzerland.
Stormann S., Schopohl J., Bullmann C., Terkamp C., Experimental and Clinical Endocrinology and Diabetes, 129(3), 224–233. https://doi.org/10.1055/a-1247-4713
, Finke R., Flitsch J., Kreitschmann-Andermahr I., Luger A., Stalla G., Houchard A., Helbig D., & Petersenn S. (2021). Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Acromegaly in Routine Clinical Practice in Germany, Austria and Switzerland.
Heilmann E, Gregoriano C, Wirz Y, Luyt CE, Wolff M, Chastre J, Tubach F, Clinical Chemistry and Laboratory Medicine, 59(2), 441–453. https://doi.org/10.1515/cclm-2020-0931
, Bouadma L, Annane D, Damas P, Kristoffersen KB, Oliveira CF, Stolz D, Tamm M., de Jong E, Reinhart K, Shehabi Y, Verduri A, et al. (2021). Association of kidney function with effectiveness of procalcitonin-guided antibiotic treatment: A patient-level meta-analysis from randomized controlled trials.
Heilmann E, Gregoriano C, Wirz Y, Luyt CE, Wolff M, Chastre J, Tubach F, Clinical Chemistry and Laboratory Medicine, 59(2), 441–453. https://doi.org/10.1515/cclm-2020-0931
, Bouadma L, Annane D, Damas P, Kristoffersen KB, Oliveira CF, Stolz D, Tamm M., de Jong E, Reinhart K, Shehabi Y, Verduri A, et al. (2021). Association of kidney function with effectiveness of procalcitonin-guided antibiotic treatment: A patient-level meta-analysis from randomized controlled trials.
Westphal L.P., Schweizer J., Fluri F., De Marchis GM, Frontiers in Neurology, 11. https://doi.org/10.3389/fneur.2020.629151
, Luft A.R., & Katan M. (2021). C-Terminal-Pro-Endothelin-1 Adds Incremental Prognostic Value for Risk Stratification After Ischemic Stroke.
Westphal L.P., Schweizer J., Fluri F., De Marchis GM, Frontiers in Neurology, 11. https://doi.org/10.3389/fneur.2020.629151
, Luft A.R., & Katan M. (2021). C-Terminal-Pro-Endothelin-1 Adds Incremental Prognostic Value for Risk Stratification After Ischemic Stroke.
Atila C., Sailer C.O., Bassetti S., Tschudin-Sutter S, Bingisser R., Siegemund M, Osswald S, Rentsch K, Rueegg M., Schaerli S., Kuster GM, Twerenbold R, & European Journal of Endocrinology, 184(3), 413–422. https://doi.org/10.1530/EJE-20-1374
. (2021). Prevalence and outcome of dysnatremia in patients with COVID-19 compared to controls.
Atila C., Sailer C.O., Bassetti S., Tschudin-Sutter S, Bingisser R., Siegemund M, Osswald S, Rentsch K, Rueegg M., Schaerli S., Kuster GM, Twerenbold R, & European Journal of Endocrinology, 184(3), 413–422. https://doi.org/10.1530/EJE-20-1374
. (2021). Prevalence and outcome of dysnatremia in patients with COVID-19 compared to controls.
Endocrinological diagnosis and replacement therapy for diabetes insipidus (pp. 147–156). Elsevier. https://doi.org/10.1016/B978-0-12-819949-7.00021-4
(2021).
Endocrinological diagnosis and replacement therapy for diabetes insipidus (pp. 147–156). Elsevier. https://doi.org/10.1016/B978-0-12-819949-7.00021-4
(2021).
Nobbenhuis R, Nobbenhuis R, Refardt J, Vogt D, Sailer CO, Winzeler B, & Biomarkers, 26(7), 647–655. https://doi.org/10.1080/1354750X.2021.1970808
. (2021). Can treatment response to SGLT2-inhibitors in syndrome of inappropriate antidiuresis be predicted by copeptin, natriuretic peptides and inflammatory markers?
Nobbenhuis R, Nobbenhuis R, Refardt J, Vogt D, Sailer CO, Winzeler B, & Biomarkers, 26(7), 647–655. https://doi.org/10.1080/1354750X.2021.1970808
. (2021). Can treatment response to SGLT2-inhibitors in syndrome of inappropriate antidiuresis be predicted by copeptin, natriuretic peptides and inflammatory markers?
Potasso L, Potasso L, Refardt J., Chifu I., Fassnacht M, Fenske W.K., & Endocrine Connections, 10(4), 401–409. https://doi.org/10.1530/EC-20-0531
(2021). Incidence of hyperkalemia during hypertonic saline test for the diagnosis of diabetes insipidus.
Potasso L, Potasso L, Refardt J., Chifu I., Fassnacht M, Fenske W.K., & Endocrine Connections, 10(4), 401–409. https://doi.org/10.1530/EC-20-0531
(2021). Incidence of hyperkalemia during hypertonic saline test for the diagnosis of diabetes insipidus.
Winzeler, Bettina, Sailer, Clara O, Coynel, David, Zanchi, Davide, Vogt, Deborah R, Urwyler, Sandrine A, Refardt, Julie, & Journal of Clinical Investigation, 131(20), e151800. https://doi.org/10.1172/jci151800
. (2021). A randomized controlled trial of the GLP-1 receptor agonist dulaglutide in primary polydipsia.
Winzeler, Bettina, Sailer, Clara O, Coynel, David, Zanchi, Davide, Vogt, Deborah R, Urwyler, Sandrine A, Refardt, Julie, & Journal of Clinical Investigation, 131(20), e151800. https://doi.org/10.1172/jci151800
. (2021). A randomized controlled trial of the GLP-1 receptor agonist dulaglutide in primary polydipsia.
Winzeler B, Sailer C.O., Coynel D., Zanchi D., Vogt DR, Urwyler SA, Refardt J, & Journal of Clinical Investigation, 131(20). https://doi.org/10.1172/JCI151800
(2021). A randomized controlled trial of the GLP-1 receptor agonist dulaglutide in primary polydipsia.
Winzeler B, Sailer C.O., Coynel D., Zanchi D., Vogt DR, Urwyler SA, Refardt J, & Journal of Clinical Investigation, 131(20). https://doi.org/10.1172/JCI151800
(2021). A randomized controlled trial of the GLP-1 receptor agonist dulaglutide in primary polydipsia.